Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia

Journal of General Virology

Volumn 81, Issue 12, 2000, Pages 2959-2968

  Villa, L L ^a   Sichero, L ^a   Rahal, P ^a   Caballero, O ^a   Ferenczy, A ^a   Rohan, T ^a   Franco, E L ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER GRADING; CANCER SCREENING; COHORT ANALYSIS; CONTROLLED STUDY; DOT HYBRIDIZATION; EUROPE; FEMALE; GENE SEQUENCE; GYNECOLOGICAL EXAMINATION; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX TUMOR; UTERUS CERVICOGRAPHY; VIRUS DETECTION; VIRUS ISOLATION; VIRUS TYPING; WART VIRUS;

EID: 0034529354     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-81-12-2959     Document Type: Article

References (45)

1. Genital human papillomavirus infection in students as determined by a PCR-based method
2. Evolution of papillomaviruses
3. Identification and assessment of known and novel human papilloma-viruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms
4. HPV-16 infection and progression of cervical intra-epithelial neoplasia: Analysis of HLA polymorphism and HPV-16 sequence variants
5. Low stringency-PCR (LS-PCR) allows entirely internally standardized DNA quantitation
6. Molecular variants of human papillomavirus-16 from four continents suggest ancient pandemic spread of the virus and its co-evolution with humankind
7. Natural variants of human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation
8. The association of an HPV-16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer
9. Human papillomavirus type 16 variant lineages characterized by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region
10. Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16
11. Molecular variant analysis as an epidemiological tool to study persistence of cervical human papillomavirus infection
12. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil
13. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer
14. Genetic characterization of the human papillomavirus (HPV)-18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential
15. Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genome samples throughout the world
16. Persistence of type-specific human papillomavirus infection among cytologically normal women
17. Sequence variants of human papillomavirus type 16 from couples suggest sexual transmission with low infectivity and polyclonality in genital neoplasia
18. Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree
19. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations
20. Nucleotide and amino acid sequence variation in the L1 and E7 open reading frames of human papillomavirus type 6 and type 16
21. Intratypic variability of HPV-16 and -18 in tumour biopsies from a high risk area for cervical cancer
22. Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity
23. Papillomavirus L1 major protein self-assembles into virus-like particles that are highly immunogenic
24. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles
25. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16
26. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions
27. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities
28. Genetic susceptibility to HPV infection and cervical cancer
29. Cervical cancer, HPV-16 E6 variant genotypes, and serology
30. Evolution of human papillomavirus type 18: An ancient phylogenetic root in Africa and intratype diversity reflect co-evolution with human ethnic groups
31. Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera
32. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase
33. Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and non-cancerous lesions of Korean women
34. Analysis of the E2 amino acid variants of human papillomavirus types 16 and 18 and their associations with lesion grade and HLA DR/DQ type
35. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis
36. Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16
37. Virus load, persistent cervical HPV infection, and cumulative risk of cervical intraepithelial neoplasia in a high-risk area
38. Molecular variant analysis as a tool in natural history studies of human papillomavirus infection and cervical neoplasia
39. Human papillomavirus type 16 sequences variants: Identification by E6 and L1 lineage-specific hybridization
40. Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection
41. Genomic variation of human papillomavirus type 16 and risk for high-grade cervical intraepithelial neoplasia
42. Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants
43. Human papillomavirus type 16 lineages in the United States populations characterized by nucleotide sequence analysis of the E6, L2 and L1 coding segments
44. Human papillomavirus type 16 sequence variation in cervical cancers: A worldwide perspective
45. The biological significance of human papillomavirus type 16 variants for the development of cervical neoplasia